Lurie Cancer Center oncologist, Dr. Al B. Benson III, presents an overview of the latest GI cancer news, including a discussion of two agents approved by the FDA in 2012 for patients with metastatic colorectal cancer.
This session will discuss the expanded role of anti-angiogenesis therapeutic approaches, with an emphasis on the continuum of care and the multiple options now available for patients.
Thursday, February 21, 2013
7:00 p.m. — 8:30 p.m.
Cancer Wellness Center
215 Revere Dr.
Northbrook, IL 60062
For registration, call 847.509.9595
or visit cancerwellness.org